← Back to Search

Software Assisted Lifestyle Counseling for Tobacco Use Disorder

Phase 2
Waitlist Available
Led By Scott Strayer, MD
Research Sponsored by Silverchair Science & Communications, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
any physician providing care for members of Southern Health through primary care and have access to a point-of-care computing device (Smartphone, desktop PC, etc) during patient visits.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

QuitAdvisorMD: A point-of-care tool for brief smoking cessation interventions Under a Phase II SBIR grant supported by NIH/NIDA, we are developing QUITAdvisorMD: a point-of-care, patient-centered resource for counseling patients who smoke or use tobacco products. It is based on the principles of Motivational Interviewing, a non-confrontational and very effective method for intervening and treating these patients; the 5 A's of behavioral interventions; and the Transtheoretical Model of Change. Through a point and click interface, the tool uses a series of interview questions designed to motivate patients to stop smoking by first assessing their stage of change and then offering effective stage-based interventions and interview techniques. The tool also offers stage-tailored patient information, a clinician educational reference, and the ability to communicate support information patients via email and/or text message.

Eligible Conditions
  • Tobacco Use Disorder
  • Smoking

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Smoke
Secondary outcome measures
will include, 1) the increase in ability of clinicians to provide appropriate stage-based smoking cessation assistance, and 2) the increase in patient quit attempts.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Software Assisted Lifestyle CounselingExperimental Treatment1 Intervention
Group II: Lifestyle CounselingActive Control1 Intervention
Status quo smoking cessation counseling.

Find a Location

Who is running the clinical trial?

Silverchair Science & Communications, LLCLead Sponsor
National Institute on Drug Abuse (NIDA)NIH
2,468 Previous Clinical Trials
2,619,249 Total Patients Enrolled
271 Trials studying Tobacco Use Disorder
48,967 Patients Enrolled for Tobacco Use Disorder
Scott Strayer, MDPrincipal InvestigatorUniversity of Virginia Health System

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Apr 2025